EFFICACY OF TENAPANOR AS A PHOSPHATE-LOWERING THERAPY IN PATIENTS WITH END-STAGE KIDNEY DISEASE: A SYSTEMATIC REVIEW AND META-ANALYSIS - International Society of Nephrology Events